We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
Hims & Hers (NYSE: HIMS) stock was a heartening comeback story on Wednesday, following something of a rout earlier in the ...
Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...
14h
Hosted on MSNWall Street's Most Wanted: 2 Highly Shorted Stocks Right NowShort-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...
TD Cowen raised the firm’s price target on Hims & Hers to $44 from $28 and keeps a Buy rating on the shares. The firm continues to believe ...
Truist analyst Jailendra Singh raised the firm’s price target on Hims & Hers to $39 from $24 and keeps a Hold rating on the shares after ...
Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on ...
The auto industry is in the spotlight today, as several major stocks react to earnings reports, strategic moves, and ...
E-commerce firm eBay forecast first-quarter revenue below Wall Street estimates on Wednesday, signaling weak demand for ...
Call traders have been chiming in as well. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and ...
The U.S. dollar firmed in early Asian hours on Thursday as Treasury yields ticked higher while investors assessed the outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results